CureVac wants to be entitled | News

CureVac sees its patents being violated by millions of sold Biontech competitor’s corona vaccines and is now suing them. Curevac shares remain on the ground, Biontech recovers.

According to CureVac, she has therefore filed a lawsuit against Biontech and the two subsidiaries of a company based in Mainz at the Düsseldorf Regional Court. The Tbingen vaccine developer is not seeking a court order or legal action that would prevent Biontech and Pfizer from producing, selling or distributing Comirnaty.

But CureVac wants to assert its intellectual property rights from over two decades of pioneering work in mRNA technology that contributed to the development of Covid-19 vaccines, including the Biontech SARS CoV-2 mRNA vaccines, which are considered essential. This success is built on decades of research and innovation, supported by CureVac as the earliest pioneer in mRNA technology. Therefore, to invest in the development of mRNA technology and new classes of life-saving drugs, intellectual property rights would have to be recognized and respected in the form of fair remuneration.

Register now and buy a Biontech share

More: https://www.etoro.com/ CFDs are complex instruments and come with a high risk of losing money rapidly through leverage. 67% of retail investor accounts lose money when trading CFDs from this provider. You should consider whether you understand how CFDs work and whether you can afford the high risk of losing your money.

Curevac was considered one of the great beacons of hope in the development of the Covid-19 vaccine, but suffered a major setback when its own vaccine did not work as well and the project was stopped. Tbingers are now working on an improved vaccine together with UK pharmaceutical company GlaxoSmithKline, while Biontech and Pfizer are generating billions of dollars in turnover with their vaccine.

Biontech’s share is collapsing due to resistance

Biontech shares have hit their lowest levels for months, but the title has recently failed with resistance just below $ 175. MACD (Momentum) continues to point up and supports the action. However, the overall downward trend has continued since August 2021. The charting technique only improves when a resistance level of just below $ 175 is breached.

Biontech’s success can be attributed to, inter alia, purchase of shares participate. Brave investors can get leverage with Buy CFDs get involved.

It’s that simple to buy stocks on eToro.

The eToro platform offers traders from all over the world the unique opportunity to add shares to their portfolio. As of early 2018, every BUY non-leveraged order causes eToro to buy the underlying asset; it will then be held on behalf of the client. This also applies to cases where you invest in CopyPortfolio or copy an investor: if the copied investor buys shares, you automatically own a portion of his share portfolio.

Trade stocks with eToro, here are the advantages:

  • trust Your shares will be held in your name in an EU regulated company.
  • insurance Your deposit and related assets are insured under CySEC’s Terms of Use.
  • dividends If the company pays dividends, investors will be allocated an appropriate dividend.
  • No care fees Buying stocks on eToro means you no Pay storage and ordering fees as well as commissions. There is a bid-ask spread when buying and selling stocks.
  • Easy-to-use Your warehouse is always available online and via the app.
  • diversification Create a portfolio of stocks, cryptocurrencies, commodities, and more.

Register now and buy shares

About eToro:

For over a decade, eToro has been at the forefront of the global fintech revolution. It is the world’s leading social trading network, with millions of registered users and a host of innovative trading and investing tools. Since the beginning of 2018, eToro allows you to buy and sell stocks.

More: https://www.etoro.com/ CFDs are complex instruments and come with a high risk of losing money rapidly through leverage. 67% of retail investor accounts lose money when trading CFDs from this provider. You should consider whether you understand how CFDs work and whether you can afford the high risk of losing your money.

advertisement

Leave a Comment